Literature DB >> 24969373

Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma.

Yuwu Liu1, Chang Wu2, Ying Wang3, Sailan Wen3, Junpu Wang3, Zhihong Chen3, Qiongqiong He3, Deyun Feng4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24969373     DOI： 10.1093/abbs/gmu052

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN： 1672-9145            Impact factor:   3.848


× No keyword cloud information.
  4 in total

1.  Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer.

Authors:  Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Xiaorong Zhu; Dilip Deb; Stephen C Meredith; Fatma Ayaloglu-Butun; Michelle Fletcher; Arantxa Sanchez; Joel Pekow; Zifeng Deng; Nader Amini; Vani J Konda; Vijaya L Rao; Atsushi Sakuraba; Akushika Kwesi; Sonia S Kupfer; Alessandro Fichera; Loren Joseph; John Hart; Fang He; Tong-Chuan He; Diana West-Szymanski; Yan Chun Li; Marc Bissonnette
Journal:  Epigenetics       Date:  2020-12-28       Impact factor: 4.528

2.  Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer.

Authors:  Huijun Xie; Xiaoli Ren; Sainan Xin; Xiaoliang Lan; Guifeng Lu; Yuan Lin; Shaoshan Yang; Zhicheng Zeng; Wenting Liao; Yan-Qing Ding; Li Liang
Journal:  Oncotarget       Date:  2016-05-03

3.  Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.

Authors:  Wataru Okajima; Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Tsutomu Kawaguchi; Shoji Hirajima; Takuma Ohashi; Taisuke Imamura; Jun Kiuchi; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Ryo Moriumura; Hisashi Ikoma; Kazuma Okamoto; Hiroki Taniguchi; Yoshito Itoh; Eigo Otsuji
Journal:  Oncotarget       Date:  2016-08-16

4.  Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.

Authors:  Charles Johannessen; Line Moi; Yury Kiselev; Mona Irene Pedersen; Stig Manfred Dalen; Tonje Braaten; Lill-Tove Busund
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.